Fuji Pharma's sales composition FY 2018, by therapeutic category

This statistic illustrates the sales distribution of the Japanese pharmaceutical company Fuji Pharma Co. Ltd. in fiscal year 2018, broken down by therapeutic category. In fiscal year 2018, diagnostic drugs made up the largest share of Fuji Pharma's sales with a share of around 37.8 percent.

Sales distribution of Fuji Pharma Co. Ltd. in fiscal year 2018, by therapeutic category

Sales share
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

November 2018



Survey time period

fiscal year 2018; fiscal year ended September 30

Special properties

consolidated data

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.